ELSBREE DAVID B sold 70.5% of their position (55.00 shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $133.10 — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/17/2024ACC: 0000950170-24-107349
-55.00
Net shares
Net seller
$133.10
Total sold
1
Open market trades
0B · 1S
1
Total transactions
55.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−55.00
Price / share
$2.42
Trade value
$133.10
% of position
70.5%
9/13/2024
78.00→23.00
Total
Net shares
−55.00
Net value
-$133.10
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/13/2024 | S · Sale | −55.00 | $2.42 | $133.10 | 70.5% | 78.00 | 23.00 |
| Total | −55.00 | -$133.10 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2.00
Total
2.00 indirect2.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.00 | Indirect |
| Total | 2.00 | 2.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported